Xing Zeng
- Molecular Biology top 10%
- Physiology top 2%
- Epidemiology top 5%
- Cancer Research top 10%
- Cardiology and Cardiovascular Medicine top 10%
- Co-authors
- Bruce M. SpiegelmanMark P. JedrychowskiZhiquan HuChunguang YangBo HuBradford B. LowellJon M. ReschJonathan Z. Long
- Topics
- Renal cell carcinoma treatment (9 papers)Natural product bioactivities and synthesis (9 papers)Bladder and Urothelial Cancer Treatments (9 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Xing Zeng
85 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 122
- Molecular Biology 1.0k
- Physiology 858
- Epidemiology 555
- Cancer Research 240
- Cardiology and Cardiovascular Medicine 232
Countries citing papers authored by Xing Zeng
This map shows the geographic impact of Xing Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xing Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xing Zeng more than expected).
Fields of papers citing papers by Xing Zeng
This network shows the impact of papers produced by Xing Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xing Zeng. The network helps show where Xing Zeng may publish in the future.
Co-authorship network of co-authors of Xing Zeng
This figure shows the co-authorship network connecting the top 25 collaborators of Xing Zeng. A scholar is included among the top collaborators of Xing Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xing Zeng. Xing Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 12 | |
| 6 | 1 | |
| 7 | 5 | |
| 8 | 16 | |
| 9 | 1 | |
| 10 | 4 | |
| 11 | 46 | |
| 12 | 0 | |
| 13 | 10 | |
| 14 | 17 | |
| 15 | 95 | |
| 16 | 68 | |
| 17 | 14 | |
| 18 | 60 | |
| 19 | 8 | |
| 20 | 8 |
About Xing Zeng
Xing Zeng is a scholar working on Complementary and alternative medicine, Pharmacology and Pulmonary and Respiratory Medicine, having authored 90 papers that have together received 2.4k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (9 papers), Natural product bioactivities and synthesis (9 papers) and Bladder and Urothelial Cancer Treatments (9 papers). The work is most often cited by research in Physiology (858 citations), Rehabilitation (212 citations) and Complementary and alternative medicine (179 citations). Xing Zeng has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Bruce M. Spiegelman, Mark P. Jedrychowski, Zhiquan Hu, Chunguang Yang, Bo Hu, Bradford B. Lowell, Jon M. Resch, Jonathan Z. Long, John J. Castellot and Rajesh R. Rao. Their work appears in journals such as Nature, Cell and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.